Relationship between total phenolic contents and biological properties of propolis from 20 different regions in South Korea

BMC Complementary and Alternative Medicine

Volumn 16, Issue 1, 2016, Pages

  Wang, Xue ^a   Sankarapandian, Karuppasamy ^a   Cheng, Yizhe ^b   Woo, Soon Ok ^c   Kwon, Hyung Wook ^a   Perumalsamy, Haribalan ^a   Ahn, Young Joon ^b  

^a Seoul National University   (South Korea)

^b Seoul National University   (South Korea)

^c National Institute of Animal Science   (South Korea)

Author keywords

Acetylcholinesterase inhibitory activity; Anti human rhinovirus activity; Antibacterial activity; Antioxidant; Antiproliferative activity; BACE 1; Correlation; Flavonoid; Korean propolis; Polyphenol

Indexed keywords

ACETYLCHOLINESTERASE; BETA SECRETASE 1; FLAVONOID; NATURAL PRODUCT; PHENOL; PHENYLPROPANOID DERIVATIVE; PROPOLIS; STILBENE DERIVATIVE; UNCLASSIFIED DRUG; ANTIINFECTIVE AGENT; CHOLINESTERASE INHIBITOR; PHENOL DERIVATIVE; SCAVENGER;

ANTIBIOTIC SENSITIVITY; ANTIOXIDANT ACTIVITY; ANTIVIRAL ACTIVITY; APITHERAPY; ARTICLE; BACTERIAL STRAIN; CELL VIABILITY; CONTROLLED STUDY; CORRELATION ANALYSIS; CORRELATION COEFFICIENT; DPPH RADICAL SCAVENGING ASSAY; ENZYME ACTIVITY; ENZYME INHIBITION; EVAPORATION; FLUORESCENCE RESONANCE ENERGY TRANSFER; GEOGRAPHIC DISTRIBUTION; GRAM NEGATIVE BACTERIUM; GRAM POSITIVE BACTERIUM; GROWTH INHIBITION; HUMAN; HUMAN CELL; INTESTINE FLORA; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; OPTICAL DENSITY; PROTEIN CONTENT; RHINOVIRUS; SOUTH KOREA; ANIMAL; BEE; CELL PROLIFERATION; CHEMISTRY; DRUG EFFECTS; METABOLISM; TUMOR CELL LINE;

ACETYLCHOLINESTERASE; ANIMALS; ANTI-BACTERIAL AGENTS; BEES; CELL LINE, TUMOR; CELL PROLIFERATION; CHOLINESTERASE INHIBITORS; FLAVONOIDS; FREE RADICAL SCAVENGERS; HUMANS; PHENOLS; PROPOLIS; REPUBLIC OF KOREA;

EID: 84958233279     PISSN: None     EISSN: 14726882     Source Type: Journal    
DOI: 10.1186/s12906-016-1043-y     Document Type: Article

References (69)

1. Marcucci MC. Propolis: chemical composition, biological properties and therapeutic activity. Apidologie. 1995;26:83-99.
2. Bankova VS, de Castro SL, Marcucci MC. Propolis: recent advances in chemistry and plant origin. Apidologie. 2000;31:3-15.
3. Burdock GA. Review of the biological properties and toxicity of bee propolis (propolis). Food Chem Toxicol. 1998;36:347-63.
4. Sforcin JM, Bankova V. Propolis: is there a potential for the development of new drugs? J Ethnopharmacol. 2011;133:253-60.
5. Farooqui T, Farooqui AA. Molecular mechanism underlying the therapeutic activities of propolis: a critical review. Curr Nutr Food Sci. 2010;6:186-99.
6. Ahn MR, Kumazawa S, Usui Y, Nakamura J, Matsuka M, Zhu F, et al. Antioxidant activity and constituents of propolis collected in various areas of China. Food Chem. 2007;101:1383-92.
7. Salatino A, Fernandes-Silva CC, Righi AA, Salatino MLF. Propolis research and the chemistry of plant products. Nat Prod Rep. 2011;28:925-36.
8. Park YK, Ikegaki M, Alencar SM, Moura FF. Evaluation of Brazilian propolis by both physicochemical methods and biological activity. Honeybee Sci. 2000;21:85-90.
9. Ahn MR, Kumazawa S, Hamasaka T, Bang KS, Nakayama T. Antioxidant activity and constituents of propolis collected in various areas of Korea. J Agric Food Chem. 2004;52:7286-92.
10. Drlica K, Zhao X. DNAgyrase, topoisomerase IV, and the 4-quinolones. Microbiol Mol Biol Rev. 1997;61:377-92.
11. Huang S, Zhang C-P, Wang K, Li GQ, Hu F-L. Recent advances in the chemical composition of propolis. Molecules. 2014;19:19610-32.
12. Watanabe MA, Amarante MK, Conti BJ, Sforcin JM. Cytotoxic constituents of propolis inducing anticancer effects: a review. J Pharm Pharmacol. 2011;63:1378-86.
13. Zongo C, Savadogo A, Ouattara L, Bassole IHN, Ouattara CAT, Ouattara AS, et al. Polyphenols content, antioxidant and antimicrobial activities of Ampelocissus grantii (Baker) Planch. (Vitaceae): a medicinal plant from Burkina Faso. Int J Pharmacol. 2010;6:880-7.
14. Lv L, Yang QY, Zhao Y, Yao CS, Sun Y, Yang EJ, et al. BACE1 (β-secretase) inhibitory chromone glycosides from Aloe vera and Aloe nobilis. Planta Med. 2008;74:540-5.
15. Wang X, Kim JR, Lee SB, Kim YJ, Jung MY, Kwon HW, et al. Effects of curcuminoids identified in rhizomes of Curcuma longa on BACE-1 inhibitory and behavioral activity and lifespan of Alzheimer's disease Drosophila models. BMC Complement Altern Med. 2014;14:88.
16. Čolović MB, Krstić DZ, Lazarević-Pašti TD, Bondžić AM, Vasić VM. Acetylcholinesterase inhibitors: pharmacology and toxicology. Curr Neuropharmacol. 2013;11:315-35.
17. Blois MS. Antioxidant determinations by the use of a stable free radical. Nature. 1958;181:1199-200.
18. Morgan DML. Tetrazolium (MTT) assay for cellular viability and activity. Methods Mol Biol. 1998;79:179-83.
19. Vichai V, Kirtikara K. Sulforhodamine B colorimetric assay for cytotoxicity screening. Nat Protoc. 2006;1:1112-6.
20. Ngan LTM, Jang MJ, Kwon MJ, Ahn YJ. Antiviral activity and possible mechanism of action of constituents identified in Paeonia lactiflora root toward human rhinoviruses. PLoS ONE. 2015;10(4):e0121629.
21. Ngan LTM, Moon JK, Kim JH, Shibamoto T, Ahn YJ. Growth-inhibiting effects of Paeonia lactiflora root steam distillate constituents and structurally related compounds on human intestinal bacteria. World J Microbiol Biotechnol. 2012;28:1575-83.
22. Sarker SD, Nahar L, Kumarasamy Y. Microtitre plate-based antimicrobial assay incorporating resazurin as an indicator of cell growth, and its application in the in vitro antibacterial screening of phytochemicals. Methods. 2007;42:321-4.
23. Suh YH, Checler F. Amyloid precursor protein, presenilins, and aα-synuclein: molecular pathogenesis and pharmacological applications in Alzheimer's disease. Pharmacol Rev. 2002;54:469-525.
24. Nijveldt RJ, van Nood E, van Hoorn DEC, Boelens PG, van Norren K, van Leeuwen PAM. Flavonoids: a review of probable mechanisms of action and potential applications. Am J Clin Nutr. 2001;74:418-25.
25. Kumar S, Pandey AK. Chemistry and biological activities of flavonoids: an overview. Scientific World J. 2013;2013:162750.
26. Boufadi YM, Soubhye J, Riazi A, Rousseau A, Vanhaeverbeek M, Nève J, et al. Characterization and antioxidant properties of six Algerian propolis extracts: ethyl acetate extracts inhibit myeloperoxidase activity. Int J Mol Sci. 2014;15:2327-45.
27. Lima B, Tapia A, Luna L, Fabani MP, Schmeda-Hirschmann G, Podio NS, et al. Main flavonoids, DPPH activity and metal content allow determination of the geographical origin of propolis from the province of San Juan (Argentina). J Agric Food Chem. 2009;57:2691-8.
28. Schmidt EM, Stock D, Chada FJG, Finger D, Sawaya ACHF, Eberlin MN, et al. A comparison between characterization and biological properties of Brazilian fresh and aged propolis. BioMed Res Int. 2014;2014:257617.
29. Kalogeropoulos N, Konteles SJ, Troullidou E, Mourtzinos I, Karathanos V. Chemical composition, antioxidant activity and antimicrobial properties of propolis extract from Greece and Cyprus. Food Chem. 2009;116:452-61.
30. Laskar RA, Ismail SK, Roy N, Begum NA. Antioxidant activity of Indian propolis and its chemical constituents. Food Chem. 2010;122:233-7.
31. Hamasaka T, Kumazawa S, Fujimoto T, Nakayama T. Antioxidant activity and constituents of propolis collected in various areas of Japan. Food Sci Technol Res. 2004;10:86-92.
32. Miguel MG, Doughmi O, Aazza S, Antunes D, Lyoussi B. Antioxidant, anti-inflammatory and acetylcholinesterase inhibitory activities of propolis from different regions of Morocco. Food Sci Biotechnol. 2014;23:313-22.
33. Socha R, Gałkowska D, Bugaj M, Juszczak L. Phenolic composition and antioxidant activity of propolis from various regions of Poland. Nat Prod Res. 2015;29:416-22.
34. Moreira L, Dias LG, Pereira JA, Estevinho L. Antioxidant properties, total phenols and pollen analysis of propolis samples from Portugal. Food Chem Toxicol. 2008;46:3482-5.
35. Aliyazicioglu R, Sahin H, Erturk O, Ulusoy E, Kolayli S. Properties of phenolic composition and biological activity of propolis from Turkey. Int J Food Prop. 2013;16:277-87.
36. Mancini F, De Simone A, Andrisano V. Bata-secretase as a target for Alzheimer's disease drug discovery: an overview of in vitro methods for characterization of inhibitors. Anal Bioanal Chem. 2011;400:1979-96.
37. Hardy J, Selkoe DJ. The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics. Science. 2002;297:353-6.
38. Liebscher S, Meyer-Luehmann M. A peephole into the brain: neuropathological features of Alzheimer's disease revealed by in vivo two-photon imaging. Front Psychiatry. 2012;3:26. doi: 10.3389/fpsyt.2012.00026.
39. Vassar R, Kovacs DM, Yan R, Wong PC. The β-secretase enzyme BACE in health and Alzheimer's disease: regulation, cell biology, function, and therapeutic potential. J Neurosci. 2009;29:12787-94.
40. Zhu A, Wu Z, Huang Y, Nakanishi H, Wu S. Brazilian propolis improves cognitive functions and regulates serum cytokine balances in patients with mild cognitive impairment at high altitude. Alzheimers Dement. 2014;10(Supplement):619-20.
41. Orhan I, Kartal M, Tosun F, Sener B. Screening of various phenolic acids and flavonoid derivatives for their anticholinesterase potential. Z Naturforsch C Bio Sci. 2007;62:829-32.
42. Thirugnanasampandan R, Raveendran SB, Jayakumar R. Analysis of chemical composition and bioactive property evaluation of Indian propolis. Asian Pac J Trop Biomed. 2012;2:651-4.
43. Thompson LA, Bronson JJ, Zusi FC. Progress in the discovery of BACE inhibitors. Curr Pharm Des. 2005;11:3383-404.
44. John V. Human β-secretase (BACE) and BACE inhibitors: progress report. Curr Top Med Chem. 2006;6:569-78.
45. Valko M, Leibfritz D, Moncol J, Cronin MTD, Mazur M, Telser J. Free radicals and antioxidants in normal physiological functions and human disease. Int J Biochem Cell Biol. 2007;39:44-84.
46. Isla MI, Zampini IC, Ordónez RM, Cuello S, Juárez BC, Sayago JE, et al. Effect of seasonal variations and collection form on antioxidant activity of propolis from San Juan, Argentina. J Med Food. 2009;12:1334-42.
47. Yang H, Dong Y, Du H, Shi H, Peng Y, Li X. Antioxidant compounds from propolis collected in Anhui, China. Molecules. 2011;16:3444-55.
48. Lagouri V, Prasianaki D, Krysta III F. Antioxidant properties and phenolic composition of Greek propolis extracts. Int J Food Prop. 2014;17:511-22.
49. Chan GC, Cheung KW, Sze DM. The immunomodulatory and anticancer properties of propolis. Clin Rev Allergy Immunol. 2013;44:262-73.
50. Li H, Kapur A, Yang JX, Srivastava S, McLeod DG, Paredes-Guzman JF, et al. Antiproliferation of human prostate cancer cells by ethanolic extracts of Brazilian propolis and its botanical origin. Int J Oncol. 2007;31:601-6.
51. Shubharani R, Sivaram V, Kishore BR. In-vitro cytotoxicity of Indian bee propolis on cancer cell lines. Int J Pharm Bio Sci. 2014;5:698-706.
52. Popolo A, Piccinelli LA, Morello S, Cuesta-Rubio O, Sorrentino R, Rastrelli L, et al. Antiproliferative activity of brown Cuban propolis extract on human breast cancer cells. Nat Prod Commun. 2009;4:1711-6.
53. Syamsudin, Simanjuntak P, Djamil R, Heffen WL. Apoptosis of human breast cancer cells induced by ethylacetate extracts of propolis. Am J Biochem Biotechnol. 2010;6:84-8.
54. Syamsudin, Wiryowidagdo S, Simanjuntak P, Heffen WL. Chemical composition of propolis from different regions in Java and their cytotoxic activity. Am J Biochem Biotechnol. 2009;5:180-3.
55. Zammit EJ, Theuma KB, Darmanin S, Muraglia M, Camilleri-Podesta MT, Buhagiar JA, et al. Totarol content and cytotoxicity varies significantly in different types of propolis. Res J Pharm Biol Chem Sci. 2013;4:1047-58.
56. Calhelha RC, Falcão S, Queiroz MJRP, Vilas-Boas M, Ferreira ICFR. Cytotoxicity of Portuguese propolis: the proximity of the in vitro doses for tumor and normal cell lines. BioMed Res Int. 2014;2014:897361.
57. Vatansever HS, Sorkun K, Gurhan SID, Ozdal-Kurt F, Turkoz E, Gencay O, et al. Propolis from Turkey induces apoptosis through activating caspases in human breast carcinoma cell lines. Acta Histochem. 2010;112:546-56.
58. Frion-Herrera Y, Diaz-Garcia A, Rodríguez-Sanchez H, Ruiz-Fuentes J, Monzote-Fidalgo L, Morier-Diaz L, et al. Cytotoxic effect of Cuban propolis extracts against tumor cells lines. American Journal of Essential Oils and Natural Products. 2013;1:112-7.
59. Kouidhi B, Zmantar T, Bakhrouf A. Anti-cariogenic and anti-biofilms activity of Tunisian propolis extract and its potential protective effect against cancer cells proliferation. Anaerobe. 2010;16:566-71.
60. Sears CL. A dynamic partnership: celebrating our gut flora. Anaerobe. 2005;11:247-51.
61. Guarner F, Malagelada JR. Gut flora in health and disease. Lancet. 2003;361:512-9.
62. Guilfoile PG, Alcamo IE. Antibiotic-Resistant Bacteria. New York: Infobase Publishing; 2007.
63. Dunn BE, Cohen H, Blaser MJ. Helicobacter pylori. Clin Microbiol Rev. 1997;10:720-41.
64. Moreno MIN, Isla MI, Cudmani NG, Vattuone MA, Sampietro AR. Screening of antibacterial activity of Amaicha del Valle (Tucumán, Argentina) propolis. J Ethnopharmacol. 1999;68:97-102.
65. Davey RW, Grange JM. Antibacterial properties of propolis (bee glue). J R Soc Med. 1990;83:159-61.
66. Boyanova L, Kolarov R, Gergova G, Mitova I. In vitro activity of Bulgarian propolis against 94 clinical isolates of anaerobic bacteria. Anaerobe. 2006;12:173-7.
67. Ugur A, Barlas M, Ceyhan N, Turkmen V. Antimicrobial effects of propolis extracts on Escherichia coli and Staphylococcus aureus strains resistant to various antibiotics and some microorganisms. J Med Food. 2000;3:173-80.
68. da Silva JFM, de Souza MC, Matta SR, de Andrade MR, Vidal FVN. Correlation analysis between phenolic levels of Brazilian propolis extracts and their antimicrobial and antioxidant activities. Food Chem. 2006;99:431-5.
69. Bonheví JS, Gutiérrez AL. The antimicrobial effects of propolis collected in different regions in the Basque Country (Northern Spain). World J Microbiol Biotechnol. 2012;28:1351-8.